Palmitic Acid MaxSpec® Standard
(Synonyms: 棕榈酸) 目录号 : GC49024A long-chain saturated fatty acid
Cas No.:57-10-3
Sample solution is provided at 25 µL, 10mM.
Palmitic acid is a long-chain saturated fatty acid that comprises approximately 25 and 65% of human total plasma lipids and saturated fatty acids, respectively.1,2 Acylation of palmitic acid to proteins facilitates anchoring of membrane-bound proteins to the lipid bilayer and trafficking of intracellular proteins, promotes protein-vesicle interactions, and regulates various G protein-coupled receptor functions.1 Palmitic acid (200 µM) increases NF-?B p65 levels, matrix metalloproteinase-9 (MMP-9) activity, and production of reactive oxygen species (ROS) in AsPC-1 pancreatic cancer cells, as well as increases migration of AsPC-1 cells.3 It increases COX-2 levels in RAW 264.7 cells and increases LPS-induced IL-1β levels and caspase-1 activity in isolated mouse peritoneal macrophages.4,5 Dietary administration of palmitic acid (2.2% w/w for 12 weeks) increases mouse hippocampal β-secretase 1 (BACE1) activity and amyloid β (1-42) levels.6 It also induces systolic contractile dysfunction in isolated mouse hearts.7 Red blood cell palmitic acid levels are increased in patients with metabolic syndrome compared to patients without metabolic syndrome and are also increased in the plasma of patients with type 2 diabetes compared to individuals without diabetes.8,9
Palmitic acid MaxSpec® standard is a quantitative grade standard of palmitic acid that has been prepared specifically for mass spectrometry and related applications where quantitative reproducibility is required. The solution has been prepared gravimetrically and is supplied in a deactivated glass ampule sealed under argon. The concentration was verified by comparison to an independently prepared calibration standard. This palmitic acid MaxSpec® standard is guaranteed to meet identity, purity, stability, and concentration specifications and is provided with a batch-specific certificate of analysis. Ongoing stability testing is performed to ensure the concentration remains accurate throughout the shelf life of the product. Note: The amount of solution added to the vial is in excess of the listed amount. Therefore, it is necessary to accurately measure volumes for preparation of calibration standards. Follow recommended storage and handling conditions to maintain product quality.
1.Fatima, S., Hu, X., Gong, R.-H., et al.Palmitic acid is an intracellular signaling molecule involved in disease developmentCell. Mol. Life Sci.76(13)2547-2557(2019) 2.Santos, M.J., LÓpez-Jurado, M., Llopis, J., et al.Influence of dietary supplementation with fish oil on plasma fatty acid composition in coronary heart disease patientsAnn. Nutr. Metab.39(1)52-62(1995) 3.Binker-Cosen, M.J., Richards, D., Oliver, B., et al.Palmitic acid increases invasiveness pancreatic cancer cells AsPC-1 through TLR4/ROS/NF-κB/MMP-9 signaling pathwayBiochem. Biophys. Res. Commun.484(1)152-158(2017) 4.Lee, J.Y., Sohn, K.H., Rhee, S.H., et al.Saturated fatty acids, but not unsaturated fatty acids, induced the expression of cyclooxygenase-2 mediated through Toll-like receptor 4J. Biol. Chem.276(20)16683-16689(2001) 5.Karasawa, T., Kawashima, A., Usui-Kawanishi, F., et al.Saturated fatty acids undergo intracellular crystallization and activate the NLRP3 inflammasome in macrophagesArterioscler. Thromb. Vasc. Biol.38(4)744-756(2018) 6.Marwarha, G., Rostad, S., Lilek, J., et al.Palmitate increases β-site AβPP-cleavage enzyme 1 activity and amyloid-β genesis by evoking endoplasmic reticulum stress and subsequent C/EBP homologous protein activationJ. Alzheimers Dis.57(3)907-925(2017) 7.Knowles, C.J., Cebova, M., and Pinz, I.M.Palmitate diet-induced loss of cardiac caveolin-3: A novel mechanism for lipid-induced contractile dysfunctionPLoS One8(4)e61369(2013) 8.Yi, L.-Z., He, J., Liang, Y.-Z., et al.Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS-LDAFEBS Lett.580(30)6837-6845(2006) 9.Kabagambe, E.K., Tsai, M.Y., Hopkins, P.N., et al.Erythrocyte fatty acid composition and the metabolic syndrome: A national heart, lung, and blood institute GOLDN studyClin. Chem.54(1)154-162(2008)
Cas No. | 57-10-3 | SDF | |
别名 | 棕榈酸 | ||
Canonical SMILES | CCCCCCCCCCCCCCCC(O)=O | ||
分子式 | C16H32O2 | 分子量 | 256.4 |
溶解度 | Ethanol : 12.82 mg/mL (50.00 mM; Need ultrasonic) | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.9002 mL | 19.5008 mL | 39.0016 mL |
5 mM | 0.78 mL | 3.9002 mL | 7.8003 mL |
10 mM | 0.39 mL | 1.9501 mL | 3.9002 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet